- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/08 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
Patent holdings for IPC class C07D 231/08
Total number of patents in this class: 58
10-year publication summary
|
4
|
4
|
4
|
5
|
5
|
4
|
3
|
1
|
3
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4880 |
4 |
| The Johns Hopkins University | 5675 |
3 |
| Allergan, Inc. | 2347 |
2 |
| FUJIFILM Corporation | 29437 |
2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 703 |
2 |
| FMC Corporation | 845 |
2 |
| Gharda Chemicals Limited | 57 |
2 |
| Jiangsu Hengrui Medicine Co., Ltd. | 707 |
2 |
| National Institute of Biological Sciences, Beijing | 99 |
2 |
| Ottawa Hospital Research Institute | 108 |
2 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 641 |
2 |
| Sunshine Lake Pharma Co., Ltd. | 597 |
2 |
| University of Ottawa | 215 |
2 |
| Ottawa Hospital Research Institute and University of Ottawa | 2 |
2 |
| The Regents of the University of California | 19961 |
1 |
| Syngenta Limited | 454 |
1 |
| Centre National de La Recherche Scientifique | 10464 |
1 |
| Bayer Cropscience AG | 2040 |
1 |
| Assistance Publique - Hopitaux de Paris | 1004 |
1 |
| D.E. Shaw Research, LLC | 86 |
1 |
| Other owners | 21 |